Volume 10, Issue 8, Pages (March 2015)

Slides:



Advertisements
Similar presentations
Volume 342, Issue 1, Pages (January 2014)
Advertisements

Volume 355, Issue 2, Pages (December 2014)
Volume 20, Issue 5, Pages (August 2017)
Volume 10, Issue 7, Pages (February 2015)
Volume 15, Issue 6, Pages (June 2009)
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 80, Issue 4, Pages (August 2011)
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
Volume 137, Issue 2, Pages e2 (August 2009)
Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma  Wasakorn Kittipongdaja, Xuesong Wu, Justine Garner, Xiping Liu,
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Volume 19, Issue 2, Pages (February 2017)
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 21, Issue 5, Pages (October 2017)
Xiaqin Sun, Yu Wu, Mingxue Gu, Yan Zhang  Cell Reports 
Volume 8, Issue 5, Pages (September 2014)
Volume 28, Issue 4, Pages (October 2015)
Volume 23, Issue 11, Pages (June 2018)
Volume 12, Issue 3, Pages (July 2015)
Volume 19, Issue 3, Pages (March 2017)
Volume 20, Issue 2, Pages (February 2018)
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Molecular Therapy - Nucleic Acids
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
SOX4 Promotes Proliferative Signals by Regulating Glycolysis through AKT Activation in Melanoma Cells  Wei Dai, Xinyuan Xu, Shuli Li, Jingjing Ma, Qiong.
Volume 25, Issue 9, Pages (September 2017)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 84, Issue 2, Pages (August 2013)
The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis
Volume 16, Issue 3, Pages (July 2016)
Volume 20, Issue 5, Pages (August 2017)
TGFβ/SMAD/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis  Man Jiang, Zhongbin Sun, Erle.
Volume 22, Issue 4, Pages (October 2015)
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Volume 23, Issue 3, Pages (March 2013)
Molecular Therapy - Nucleic Acids
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Volume 6, Issue 4, Pages (October 2007)
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 85, Issue 2, Pages (January 2014)
Volume 10, Issue 2, Pages (January 2015)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
Volume 18, Issue 12, Pages (March 2017)
Volume 10, Issue 7, Pages (February 2015)
Volume 25, Issue 1, Pages (January 2017)
Volume 25, Issue 3, Pages (March 2017)
Volume 17, Issue 12, Pages (December 2016)
Volume 43, Issue 1, Pages (July 2011)
Volume 129, Issue 2, Pages (April 2007)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Molecular Therapy - Nucleic Acids
Teemu P. Miettinen, Mikael Björklund  Cell Reports 
Volume 26, Issue 11, Pages e4 (March 2019)
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Molecular Therapy - Nucleic Acids
Shuai Jiang, Wei Yan, Shizhen Emily Wang, David Baltimore 
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 44, Issue 6, Pages (June 2016)
Targeting DCLK1 by miRNA-137.
Volume 26, Issue 11, Pages e6 (March 2019)
Presentation transcript:

Volume 10, Issue 8, Pages 1335-1348 (March 2015) Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation  Daoxiang Zhang, Yongbin Wang, Zhimin Shi, Jingyi Liu, Pan Sun, Xiaodan Hou, Jian Zhang, Shimin Zhao, Binhua P. Zhou, Jun Mi  Cell Reports  Volume 10, Issue 8, Pages 1335-1348 (March 2015) DOI: 10.1016/j.celrep.2015.02.006 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 1 Cell Metabolism Switches to Glycolysis during CAF Formation (A) Tumor growth-promoting effects of isolated CAFs and induced CAFs as shown in the growth curve plot (∗p < 0.01; #p < 0.01); the image to the right displays representative tumors. (B) The pH value changes during CAF formation. (Left) Color of culture medium with or without TGF-β1/PDGF treatment. The first two plots display pH values with or without the indicated treatments (∗p < 0.05). The last two plots show the relative proliferation ratio (proliferation value in induced CAFs divided by the proliferation value in control fibroblast) with indicated treatments. (C) Lactate production in induced CAF cells, with the concentration measured by colorimetric method at the indicated time points (1, 2, and 3 hr) (∗p < 0.001). (D) Glucose uptake in fibroblasts or TGF-β-induced CAFs with or without treatment of [3H] labeled 2-DG. (E) Basal oxygen consumption, oxidative phosphorylation (with oligomycin treatment), and maximum respiration capacity (with FCCP treatment) of fibroblasts. Bar plots show the basal oxygen consumption (mean ± SD) of fibroblasts with or without stimulation (∗p < 0.001). Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Downregulation of IDH3α Promotes Glycolysis in Fibroblasts (A) Heat map of gene expression in normal fibroblasts and TGF-β-induced CAFs. A list of the predominant genes involved in glucose metabolism that are up- or downregulated is presented. (B) Western blot analysis of IDH3α expression in fibroblasts treated with indicated concentrations of TGF-β1. (C) IDH3α expression at the indicated time points after TGF-β1 stimulation. The middle plot shows densitometry analysis of the IDH3α protein level and the right plot presents the quantitative mRNA level of IDH3α (∗p < 0.01). (D) Analysis of IDH3α protein stability after MG132 and chloroquine treatments. (E) IDH3α is downregulated in colon CAFs. Paraffin-embedded colon cancer samples were co-stained with IDH3α and FSP1 antibodies. (F) Expression of IDH3α (western blot) and glycolysis-related genes (mRNA analysis) in CAF cells isolated from colon cancer samples (∗p < 0.01). (G) Analysis of lactate production and glucose uptake in fibroblasts depleted of IDH3α. Lactate production was measured at indicated time points (∗p < 0.01). (H) Analysis of lactate production and glucose uptake in fibroblasts overexpressing IDH3α. Lactate production was measured at indicated time points (∗p < 0.01). (I) Basal oxygen consumption, oxidative phosphorylation, and maximum respiration capacity of fibroblasts after IDH3α knockdown. The histogram displays the basal level of oxygen consumption (∗p < 0.01). (J) Basal oxygen consumption, oxidative phosphorylation, and maximum respiration capacity of fibroblasts with IDH3α overexpression. The histogram displays the basal level of oxygen consumption (∗p < 0.01; #p < 0.05). Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 3 miR-424 Regulates the Expression of IDH3α (A) Potential miRNAs regulating IDH3α expression. The blue oval lists the upregulated miRNAs determined by deep sequencing and the green oval lists the miRNAs predicted to regulate IDH3α (http://starbase.sysu.edu.cn; Yang et al., 2011). The histogram shows the level of miR-424 after TGF-β treatment. (B) miR-424, but not miR-181a, regulates IDH3α expression. (Top) Luciferase activity for IDH3α 3′ UTR. (Bottom) Luciferase activity in wild-type or mutant IDH3α 3′ UTR groups (∗p < 0.01). The nucleotides indicated in red for the IDH3α seed sequence were mutated to complementary nucleotides. (C) miR-424 mediates TGF-β-induced IDH3α downregulation. The IDH3α protein level in fibroblasts with miR-424 knockdown or overexpression, and in TGF-β1-treated fibroblasts with or without miR-424 depletion. (D) Effects of miR-424 overexpression on aerobic glycolysis. The mRNA level of Glut1, HK2, and PFKM in the fibroblasts overexpressing miR-424 or IDH3α (top left). The rate of lactate production (top right) and glucose uptake (bottom) analyzed in fibroblasts overexpressing miR-424. Bottom diagram shows the effect of miR-424 overexpression on basal oxygen consumption, oxidative phosphorylation, and maximum respiration capacity. Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Downregulation of IDH3α Inhibits PHD Activity (A) Potential mechanism by which IDH3α regulates HIF-1α stability. (B) Total content of α-KG, succinate, and fumurate were analyzed by GC-MS. The histograms display the relative content of α-KG, succinate, and fumurate in CAFs or fibroblasts depleted of IDH3α (∗p < 0.01). (C) Enzymes involved in glutamate conversion into α-KG were screened by quantitative PCR (bar plot). The increase of ALT2 expression was further validated by dose-response experiment in fibroblasts treated with TGF-β or PDGF. (D) ODD luciferase activity was measured in fibroblasts depleted of IDH3α or treated with 100 μM CoCl2. (E) ODD luciferase activity was measured in fibroblasts treated with 100 μM α-KG or succinate, or mixtures of α-KG (100 μM) with various concentrations of succinate (100, 200, 300, or 400 μM, respectively); the values were normalized to control. (F) Effect of IDH3α on hydroxylation of HIF-1α. The hydroxylation level of HIF-1α was detected in fibroblasts depleted of or overexpressing IDH3α, using antibody against hydroxylated HIF-1α at proline 564. Fibroblasts were treated with 5 mg MG132 for 6 hr before analysis. (G) PHD2, but not PHD1 or PHD3, regulates HIF-1α stability. Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 5 Downregulation of IDH3α Promotes Glycolysis by Increasing HIF-1α Stability (A) Expression of HIF-1α, but not HIF-2α, HIF-3α, or c-Myc, increases in CAF cells. (B) Stabilization of HIF-1α protein in induced CAF cells. Western blot shows increased protein level of HIF-1α, whereas mRNA expression is not changed. (C) IDH3α regulates HIF-1α stabilization. (Top) Western blot shows the protein level of HIF-1α after overexpression or knockdown of IDH3α; mRNA level after IDH3α knockdown. (Bottom) Western blot shows expression of glycolysis-related proteins in fibroblasts treated with the HIF-1α inhibitor YC-1 or depleted of IDH3α; lactate production in fibroblasts with IDH3α knockdown and YC-1 treatment. (D) miR-424 affects HIF-1α protein stabilization. (Top) Western blot (left) and quantitative PCR (right) of HIF-1α was performed in fibroblasts with miR-424 knockdown or overexpression. (Bottom) Western blot shows expression of proteins involved in glycolysis in fibroblasts with YC-1 treatment and/or miR-424 overexpression; lactate production in fibroblasts with miR-424 overexpression and YC-1 treatment. (E) HIF-1α activator CoCl2 restores IDH3α-inhibited glycolysis. Western blot shows the effect of CoCl2 on the expression of genes involved in glycolysis; histogram shows the effects of CoCl2 on lactate production in fibroblasts with IDH3α knockdown or IDH3α overexpression. Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 6 Downregulation of IDH3α Inhibits Oxidative Phosphorylation by Upregulating NDUFA4L2 Expression (A) (Top) Expression of NDUFA4L2, but not PGC1α or TFB1M, is upregulated in CAFs. (Bottom) Western blot displays an increase of NDUFA4L2 in the time-course and dose-response experiments. (B) Downregulation of IDH3α increases expression of NDUFA4L2. mRNA analysis (plot) shows expression of NDUFA4L2 after knockdown of IDH3α or YC-1 treatment. Western blot displays protein level of NDUFA4L2 after overexpression or knockdown of IDH3α and/or YC-1 treatment. (C) miR-424 upregulates the mRNA level and protein level of NDUFA4L2. (D) IDH3α regulates the OCR through NDUFA4L2. Plot on the left displays the basal level of oxygen consumption (∗p < 0.01). Diagram on the right shows basal oxygen consumption, oxidative phosphorylation, and maximum respiration capacity of fibroblasts with IDH3α overexpression. Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions

Figure 7 IDH3α Knockdown Contributes to Tumor-Promoting Effects of CAFs (A) IDH3α knockdown enhances tumor growth-promoting effect of CAF. (Left) Injection sites in xenograft mouse model. (Middle) Tumor growth of A375 cells co-injected with control or fibroblasts depleted of IDH3α (∗p < 0.01). (Right) Representative tumors. Corresponding positions in pictures indicate tumors taken from the same mouse. (B) IDH3α overexpression impairs tumor growth-promoting effect of CAF. (Left) Injection sites in xenograft mouse model. (Middle) Tumor growth of A375 cells co-injected with control or fibroblasts overexpressing IDH3α (∗p < 0.01). (Right) Representative tumors. (C) miR-424 overexpression enhances tumor growth-promoting effect of CAF. (Left) Injection sites in xenograft mouse model. (Middle) Tumor growth of A375 cells co-injected with control or fibroblasts overexpressing miR-424 (∗p < 0.01). (Right) Representative tumors. (D) Our model: miR-424-mediated downregulation of IDH3α promotes aerobic glycolysis through an increase in HIF-1α stability in CAFs. Cell Reports 2015 10, 1335-1348DOI: (10.1016/j.celrep.2015.02.006) Copyright © 2015 The Authors Terms and Conditions